A groundbreaking treatment for prostate cancer now available in Virginia aims to improve patient outcomes while minimizing side effects associated with traditional surgeries and radiation therapies.

The American Medical Association and more than two dozen other health organizations joined in an amicus brief encouraging the ...

Norm Clarke, a sports writer for The Associated Press who covered the world champion Cincinnati Reds and later was a popular entertainment columnist in Las Vegas, has died at 82 ...

Joseph Mossel is the CEO of Ibex Medical Analytics. His career in the tech industry spans more than 20 years, starting off in ...

A panel of experts at a leading speciality society announced in a new clinical guideline that they have decided not to decide ...

"The clinical promise of pocenbrodib, our potential best-in-class CBP/p300 inhibitor, lies not only in its remarkable efficacy in resistant prostate cancer models, but also in our sophisticated ...

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement ...

Cancer research breakthroughs will have profound impacts on the life insurance industry. What advisors need to know.

Fusion biopsy and patient follow-up with 3D mapping are the cornerstone of a successful Focal Therapy program. In line with ...

In what's expected to soon be commonplace, artificial intelligence is being harnessed to pick up signs of cancer more ...

As Quibim prepares to enter the U.S. market, the FDA clearance serves as a testament to the company's dedication to innovation and excellence in medical imaging. The QP-Prostate system is now ready to ...